Research / FTI / Fundamental state Inspectable configuration
State dimensions Filing 0001681459-25-000036 General Corporate
Debt relative to revenue 0th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
9.75% · OPTIONAL · VALID
Capex intensity 90th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
3.10% · OPTIONAL · VALID
Operating cash generation 75th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
10.58% · OPTIONAL · VALID
Revenue growth 80th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
16.09% · CORE · VALID
Inventory pressure 10th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
11.85% · OPTIONAL · VALID
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
18.95% · CORE · NOT_ENOUGH_HISTORY
Operating margin 90th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
12.74% · CORE · VALID
R&D intensity 15th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
0.81% · OPTIONAL · VALID
SBC intensity 100th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.64% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 39 states Self-history eligible
Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 7/8 normalized Level 3 Mar 31, 2022 7/7 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 7/8 normalized Level 3 Mar 31, 2023 7/7 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Dec 31, 2023 7/8 normalized Level 3 Mar 31, 2024 7/7 normalized Level 3 Jun 30, 2024 7/7 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 8/9 normalized Level 3 Mar 31, 2025 7/8 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 8/8 normalized Level 3 Mar 31, 2026 7/7 normalized Level 3 Jun 30, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 41.16%
Current 9.75%
Delta -31.42% Capex Intensity Increased
Previous 2.24%
Current 3.10%
Delta 0.86% Cash Generation Decreased
Previous 11.83%
Current 10.58%
Delta -1.25% Growth Increased
Previous 14.17%
Current 16.09%
Delta 1.92% Inventory Pressure Decreased
Previous 48.65%
Current 11.85%
Delta -36.79% Profitability Decreased
Previous 13.73%
Current 12.74%
Delta -0.99% R And D Intensity Increased
Previous 0.66%
Current 0.81%
Delta 0.15% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.